slide 2

Precision Digital Diagnostics and HealthTech

We develop aptamers and integrate them into platforms to produce next-generation digital diagnostics solutions. Our expertise lends itself to develop novel diagnostic solutions and enter various markets of interest.
Our business is based on two key components:
1) development of novel aptamers to address the diagnostic need and
2) integration of developed aptamers onto biosensor platforms to provide a total diagnostic solution. The two components lead to a successful market entry and product launch.

Our Technology

blog image 1

Aptamers are smart DNA sequences. We make aptamers that fit the biomarker target and solve the disease puzzle.

We integrate our aptamers into digital diagnostic platforms.

blog image 2
blog image 1

Our digital diagnostic platforms are integrated into total diagnostic solutions

The AlhenaBio Team

The Founders

Dr Andrew Kinghorn

Postdoctoral Research Fellow, School of Biomedical Sciences, The University of Hong Kong.

Dr Shalen Kumar

Former Adjunct Aptamer Research Fellow, Victoria University of Wellington Former CEO and Founder AuramerBio Ltd (NZ) (2015-2020) Founding Director iQ Science Ltd (NZ) (2020)

Prof Julian Tanner

Associate Director, School of Biomedical Sciences, The University of Hong Kong.

The Advisors

Prof Timothy Rainer, Medical Advisor

Clinical Professor of Emergency Medicine and Head of the Emergency Medicine Unit in the LKS Faculty of Medicine, HKU. Over 25 years researching early molecular biomarkers in stroke.

Dr Joseph Tam, Scientific and Business Advisor

Founder and Chairman of the Board of DiagCor Bioscience. Professor Over 30 years experience in the biotechnology and diagnostics sector.

News and Events

Check out our latest posts.

blog image 1
Entrepreneurship talk series
blog image 3
Join the AlhenaBio team!

Publications

A selection of our publications.

Publication 1
Measuring luteinising hormone pulsatility with a robotic aptamer-enabled electrochemical reader
Publication 2
Evolution of abiotic cubane chemistries in a nucleic acid aptamer allows selective recognition of a malaria biomarker
Publication 3
Aptamer Affinity Maturation by Resampling and Microarray Selection
Publication 4
Label-free electrochemical aptasensor for femtomolar detection o f17β-estradiol

Contact us

Type your message here.
We will get back to you shortly.
Copyright © 2020 AlhenaBio Limited